Television coverage of the Barcelona Biomed Conference on Alzheimer's disease, organized by Natàlia Carulla from IRB and Christopher M. Dobson from the University of Cambridge, which highlighted the need for increased investment into research into this disease.
A Barcelona BioMed Conference on Alzheimer’s disease organized by Natàlia Carulla from IRB and Christopher M. Dobson from the University of Cambridge with the support of BBVA Foundation has attracted attention from written and digital press.
Impact in the media of the study led by Eduard Batlle on the role of the BMP protein as a safety mechanism to restrict colon tumour formation. The article has been published in Nature Cell Biology.
«Our study highlights the complexity of p38 functions, both in cancer and in the maintenance of normal tissues. It shows why an inhibitor of this molecule could effectively have undesirable side effects. But these do not exclude it from being a target against cancer.»
More on this news here.
«98% of the potential therapeutic molecules against diseases of the central nervous system cannot cross the blood-brain barrier. We develop peptides with the capacity to open the doors of the barrier and act as shuttles when attached to a therapeutic molecule.»
«Controlling a biological process from outside is the future of chemistry and opens up promising roads for advancements in pharmacological research.»
More info on this news here.
Felice Alessio Bava
ex PhD student in the Translational Control of Cell Cycle and Differentiation Lab
«We suspected that CPEB1, a protein involved in regulating mRNA translation in the cytoplasm, might also be active in the nucleus and play a role in controlling pre-mRNA processing. We discovered that it affects the alternative generation in the mature mRNA of the 3'-UTR, regions where most of the elements regulating translation in time and space are located.»
More info about this news here.